Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients (Clinical Rheumatology, (2022), 10.1007/s10067-022-06348-z)

Yael Pri-Paz Basson, Oshrat E. Tayer-Shifman, Rawand Naser, Shelly Tartakover Matalon, Oded Kimhi, Raz Gepstein, Tamar Halperin, Tomer Ziv-Baran, Amit Ziv, Roma Parikh, Shaye Kivity*, Yair Levy

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

In the original published version of the above article, the co-author‘s name was incorrectly presented as "Oshrat E. Tayar‑Shifman". This is now corrected as "Oshrat E. Tayer- Shifman" and cited correctly as, "Tayer-Shifman, O.E.". The original article has been corrected.

Original languageEnglish
JournalClinical Rheumatology
DOIs
StateAccepted/In press - 2022

Fingerprint

Dive into the research topics of 'Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients (Clinical Rheumatology, (2022), 10.1007/s10067-022-06348-z)'. Together they form a unique fingerprint.

Cite this